Sep 25, 2020
2:1
For every share held, investors received 2. The price per share adjusted from $738.70 to $369.35.
The split itself did not change the total investment value.
Cohance Lifesciences Ltd (NSE:COHANCE) operates in the Pharmaceuticals: major industry.
Cohance Lifesciences Ltd company overviewCohance Lifesciences Ltd's most recent stock split was on September 25, 2020. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
Cohance Lifesciences Ltd has split its stock once. This history records one forward split, on September 25, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Cohance Lifesciences Ltd's 2-for-1 split on September 25, 2020, every share became 2 shares.
Cohance Lifesciences Ltd has not announced a new split in our records. Its most recent split was on September 25, 2020, 6 years ago. Companies announce splits in advance, and any new NSE:COHANCE split will appear on this page.
Already premium?